Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals multiple concerns: lowered revenue and EBITDA guidance for 2025, increased net loss, and nonrenewal of a major contract. Despite some positive developments, such as the CrimeTracer Gen3 launch and SafePointe momentum, the Q&A highlighted uncertainties in international deployments and cost-saving measures, with management providing unclear responses. The negative sentiment is further reinforced by reduced revenue retention and the failure to meet EBITDA guidance. These factors suggest a likely negative stock price reaction over the next two weeks.
Full Year Revenue $104.1 million, representing a 2% increase over 2024. The increase was achieved despite challenges, including the nonrenewal of a $9 million Chicago contract, which was replaced by growth in other product sales.
Annual Recurring Revenue (ARR) $95.4 million at the end of 2025, with an expected growth of approximately 15% or $14.6 million in 2026. The growth is net of $3.1 million of ARR attrition.
Fourth Quarter Revenue $24.8 million, representing a 6% increase over the prior year period. The increase was attributed to growth in product sales and operational efficiency measures.
Gross Profit (Full Year) $56.6 million or 54% of revenue, compared to $57.9 million or 57% of revenue in 2024. The decrease in gross profit margin was due to the nonrenewal of the Chicago contract.
Adjusted EBITDA (Full Year) $12.6 million, compared to $14.4 million in 2024. The decrease was due to delayed contracts, including CrimeTracer in a new state and ShotSpotter renewal in Puerto Rico.
Operating Expenses (Full Year) $65.4 million or 63% of revenue, compared to $65.7 million or 64% of revenue in 2024. The slight decrease was due to cost management efforts.
Sales and Marketing Expense (Full Year) $26.1 million or 25% of total revenue, compared to $28.1 million or 28% of total revenue in 2024. The decrease was due to improved efficiency in sales and marketing efforts.
Research and Development (R&D) Expense (Full Year) $15.9 million or 15% of total revenue, compared to $13.9 million or 14% of total revenue in 2024. The increase was due to investments in AI modeling and tools.
General and Administrative (G&A) Expense (Full Year) $23.2 million or 22% of total revenue, compared to $23.9 million or 23% of total revenue in 2024. The decrease was due to cost management efforts.
Net Loss (Full Year) $9.4 million or $0.74 per share, compared to $9.2 million or $0.72 per share in 2024. The slight increase in net loss was due to delayed contracts and investments in growth areas.
Deferred Revenue (End of 2025) $43.9 million, consistent with the end of the third quarter of 2025.
Revenue Retention Rate (2025) 99%, reduced due to the nonrenewal of the Chicago ShotSpotter contract at the end of 2024.
Cash and Cash Equivalents (End of 2025) $15.8 million, compared to $11.8 million at the end of the third quarter of 2025. The increase was due to operational cash flow and share repurchases.
ShotSpotter: Went live in 10 new cities, 2 universities, and expanded with 11 current customers in 2025. Exited 2025 with $67.6 million ARR and expects to add $8.3 million ARR in 2026.
CrimeTracer Gen 3: Launched late last year, applying generative AI for investigative intelligence. Exited 2025 with $8.1 million ARR and expects to add $3.1 million ARR in 2026.
PlateRanger: Gaining traction after launch last year. Targeting $1.5 million of new ARR in 2026.
SafePointe: Strong momentum with $1.6 million bookings in 2025 and expects to contribute $4 million ARR in 2026.
Market Expansion: Expanded ShotSpotter to 10 new cities, 2 universities, and 11 existing customers. Added new leadership in Brazil to accelerate growth in that market.
Strategic Partnerships: Partnership with Rekor for PlateRanger and integration with Thomson Reuters CLEAR for CrimeTracer.
Operational Efficiency: Sales and marketing spend per dollar of new annualized contract value decreased from $0.63 in 2024 to $0.56 in 2025.
Leadership Changes: Added new Senior VP of Global Sales, VP of Sales for SafePointe, and VP in Brazil to strengthen execution and expand market reach.
Strategic Shifts: Focused on integrating AI into products and workflows, emphasizing multi-product customer solutions over single-product deployments.
Revenue Guidance Adjustment: Reduced 2026 revenue guidance from $114-$116 million to $109-$111 million due to delays in CrimeTracer and ShotSpotter contracts.
Delayed Contracts: The company faced delays in the execution of two significant contracts: CrimeTracer deployment across 18 agencies in a new state and the ShotSpotter renewal in Puerto Rico. These delays have impacted revenue projections for 2026, reducing expected revenue by over $5 million.
Revenue Guidance Reduction: The company reduced its full-year revenue guidance for 2026 from $114-$116 million to $109-$111 million due to the delayed contracts and uncertain timing of their execution.
Adjusted EBITDA Margin Reduction: The adjusted EBITDA margin guidance was reduced from 18%-20% to 16%-18%, reflecting the impact of delayed contracts and continued investments in AI modeling and tools.
Chicago Contract Nonrenewal: The nonrenewal of the Chicago ShotSpotter contract at the end of 2024 has affected revenue and profitability measures for 2025 and 2026.
Market Competition: The company faces competitive pressures, particularly in the ALPR (automated license plate recognition) market, where controversies around other vendors have created both challenges and opportunities.
Operational Challenges: The company operated below full potential in 2025 due to the absence of a permanent Senior VP of Global Sales, which impacted sales execution and pipeline discipline.
Economic and Budgetary Uncertainties: The timing of revenue recognition is influenced by procurement cycles, deployment schedules, and budget headwinds, adding uncertainty to financial performance.
Annual Recurring Revenue (ARR) Growth: The company expects to grow its ARR base by approximately 15% in 2026, adding $14.6 million net of $3.1 million ARR attrition. This positions the company to enter 2027 with $110 million in ARR.
Revenue Guidance for 2026: The company has adjusted its full-year revenue guidance to $109 million to $111 million, down from the previous range of $114 million to $116 million, due to delays in contract bookings and deployments.
ARR Growth by Product: ShotSpotter is expected to add $8.3 million in ARR, including $2.7 million from Puerto Rico and $5.6 million from other new customers. CrimeTracer is projected to add $3.1 million in ARR, including $2.5 million from a delayed state-wide deployment. PlateRanger is targeting $1.5 million in new ARR, and SafePointe is expected to contribute $4 million in ARR.
Adjusted EBITDA Margin Guidance: The company has reduced its adjusted EBITDA margin guidance to 16%-18%, down from 18%-20%, due to delayed contract executions and ongoing investments in AI modeling and tools.
Strategic Focus Areas for 2026: The company aims to drive ARR growth, introduce customers to more solutions within its platform, and maintain operating discipline by focusing on high-return growth areas like SafePointe and leveraging AI capabilities.
Pipeline Visibility and Long-Term Value: The company remains optimistic about its pipeline visibility for 2026, strong customer renewal rates, and the potential for long-term value creation through strategic partnerships and integrations.
Share Repurchase: We repurchased 225,334 of our shares at an average price of $13.15 for approximately $3 million throughout 2025.
The earnings call reveals multiple concerns: lowered revenue and EBITDA guidance for 2025, increased net loss, and nonrenewal of a major contract. Despite some positive developments, such as the CrimeTracer Gen3 launch and SafePointe momentum, the Q&A highlighted uncertainties in international deployments and cost-saving measures, with management providing unclear responses. The negative sentiment is further reinforced by reduced revenue retention and the failure to meet EBITDA guidance. These factors suggest a likely negative stock price reaction over the next two weeks.
The earnings call reveals a mix of positive and negative factors. While there is optimism about new product launches, market expansion, and AI investments, there are concerns about delayed deals, gross margin declines, and conservative guidance. The Q&A highlights unresolved issues, such as the CrimeTracer deal and Puerto Rico renewal, which contribute to uncertainty. Overall, the sentiment is balanced, leading to a neutral prediction.
The earnings call presents a mixed picture: while revenue grew by 12%, the GAAP net loss widened significantly. The international expansion and SafePointe opportunities are promising, but the decrease in deferred revenue and cash reserves is concerning. The Q&A reveals optimism in market opportunities and competitive positioning, but management's vague responses on key projects like the Chicago RFP and sniper threat solution add uncertainty. The reaffirmed revenue guidance is positive, but reduced EBITDA margin guidance and cash flow concerns balance out the outlook, leading to a neutral stock price prediction.
The earnings call presents a mixed outlook. Positive elements include record revenue growth, international expansion, and product innovation. However, these are counterbalanced by an EPS miss, tariff impacts, and potential risks from municipal funding and contract delays. The Q&A section reveals positive sentiment towards product pipelines and international opportunities, but management's unclear responses on certain topics raise concerns. The share repurchase is a positive signal, yet the financial health is mixed with improved revenue but a net loss. Overall, the stock price is likely to remain stable, resulting in a 'Neutral' sentiment.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.